OMR Global, Market Research company

The g lobal disease control and prevention vaccine market  is anticipated to grow at a considerable CAGR of 12.1% during the forecast period (2022-2028). All the major players in the global disease control and prevention vaccine market are involved in strategic alliances such as acquisitions, partnerships, and collaborations to launch new vaccines to stay competitive in the market. For instance, in February 2021, US FDA approved the COVID-19 vaccine of Johnson and Johnson Services Inc., as emergency use authorization for its single dose vaccine to prevent COVID-19 in individuals above 18 years. To Request a Sample of our Report on Disease Control and Prevention Vaccine Market :   https://www.omrglobal.com/request-sample/disease-control-and-prevention-vaccine-market Further, several vaccine manufacturers are working in partnership with WHO, UNICEF, and Global Alliance for Vaccine and Immunization (GAVI) to improve the vaccination program globally for reducing the numbe...

The global dipeptidyl peptidase-4 (DPP-4) inhibitors market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The major factors that are expected to boost the market growth include increasing incidences of diabetes, particularly type-2 diabetes, as well as an increase in obesity populations. Moreover, an increase in clinical trials on the DPP-4 drugs is another factor that is expected to accelerate the growth of the market during the forecast period. The prevalence of diabetes in 2019 across the globe was more than 463 million and is projected to increase during the forecast period as per the International Diabetes Federation (IDF). The dipeptidyl peptidase 4 (DPP-4) inhibitors support in the release of insulin secretion in the patients' body and regulate the sugar levels in the body. Hence, such factors are likely to enhance the growth of the market during the forecast period. However, numerous side effects associated with the intake of dipeptidy...

The global chikungunya fever drugs market is anticipated to grow at a significant CAGR 6.3% during the forecast period (2022-2028). Chikungunya is a mosquito borne viral disease caused by the RNA virus belonging to the alphavirus genus of family Togaviridae. Its transmission from human to human is facilitated by the bites of infected female mosquitoes. The prevalence of chikungunya fever has been reported in more than 60 countries of Asia, Africa, Europe and the Americas, to date. Most commonly, the genus of mosquitoes responsible for the cause of the disease include Aedes aegypti and Aedes albopictus. Presently, there is no cure for the disease, although the treatments are focused only to address the symptoms. In 2019, according to the World Health Organization, 349 936 suspected and 146 914 laboratory confirmed cases of chikungunya were reported to the PAHO regional office. Countries that reported the most cases were Brazil (265,000 suspected cases), Bolivia and Colombia (19,000 ...

The global disposable surgical kits market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Disposable surgical kits are cost-effective as well as supports in eliminating the need for instrument cleaning and recycling along with reducing infection associated with surgery. The major factor for the growth of the market is the increasing demand for cost-effective surgical products coupled with the increasing awareness about hygiene in developing economies. Moreover, the market is also growing due to the increasing number of surgeries across the globe. According to World Health Organization (WHO), millions of people undergo surgical treatment and surgical interventions that accounts for an estimated 13% of the globe’s total disability-adjusted life years (DALYs). Hence, the increasing number of surgeries is increasing the demand for disposable surgical kits, which, in turn, is driving the market growth.  To Request a Sample of our Report on Disposa...